Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go.

Details

Ressource 1Request a copy Sous embargo indéterminé.
State: Public
Version: author
Serval ID
serval:BIB_4C3B2EADE95C
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go.
Journal
European Journal of Cardiovascular Prevention and Rehabilitation
Author(s)
Firmann M., Marques-Vidal P., Paccaud F., Mooser V., Rodondi N., Waeber G., Vollenweider P.
ISSN
1741-8275 (Electronic)
ISSN-L
1741-8267
Publication state
Published
Issued date
2010
Peer-reviewed
Oui
Volume
17
Number
6
Pages
682-687
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
BACKGROUND: There is little information regarding the prevalence and management of dyslipidaemia in Switzerland.
DESIGN: Cross-sectional population-based study of 3238 women and 2846 men aged 35-75.
METHODS: Dyslipidaemia prevalence, treatment and control were defined according to PROCAM guidelines adapted to Switzerland.
RESULTS: About 29% of the overall sample presented with dyslipidaemia, of which 39% were treated and 58% of those treated were controlled. Among the 710 patients with personal history of cardiovascular disease (CVD) and/or diabetes, 632 (89%) presented with dyslipidaemia, of which 278 (44%) and 134 (21%) patients were treated and adequately controlled, respectively. On multivariate analysis, hypolipidaemic drug treatment was positively related with age and body mass index (P for trend <0.001), and negatively related with smoking status (P for trend <0.002), whereas personal history of CVD and/or diabetes had no effect [odds ratio (OR)=1.12, 95% confidence interval (CI): 0.90-1.38]. Adequate control of lipid levels was negatively related with female sex (OR=0.65, 95% CI: 0.45-0.94) and personal history of CVD and/or diabetes (OR=0.42, 95% CI: 0.30-0.59). When personal history of CVD and/or diabetes was replaced by PROCAM risk categories, patients in the highest risk were also less well controlled.
CONCLUSION: In this population-based study, one-third of the participants was dyslipidaemic, but less than half was treated and only one-fifth was adequately controlled. The low treatment and control levels among individuals at high risk for CVD calls for a better application of recommendations regarding personal preventive measures.
Keywords
Adult, Aged, Cardiovascular Diseases/epidemiology, Chi-Square Distribution, Cross-Sectional Studies, Diabetes Mellitus/epidemiology, Dyslipidemias/drug therapy, Dyslipidemias/epidemiology, Female, Guideline Adherence, Humans, Hypolipidemic Agents/therapeutic use, Logistic Models, Male, Middle Aged, Odds Ratio, Practice Guidelines as Topic, Prevalence, Risk Assessment, Risk Factors, Switzerland/epidemiology, Time Factors, Treatment Outcome
Pubmed
Web of science
Create date
27/10/2010 13:39
Last modification date
20/08/2019 14:00
Usage data